Ellagic Acid (CID 5281855) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(245)
 
 
Inactive(654)
 
 
Inconclusive(110)
 
 
Unspecified(123)
 
 
Top Targets:
7TM GPCR Srx(19)
 
 
Bcl-2 like(14)
 
 
 
Pyr redox dim(10)
 
 
 
 
HELICc(8)
 
 
 
 
Tubulin-bindi..(7)
 
 
 
BioAssay Types:
Confirmatory(433)
 
 
 
 
 
Screening(357)
 
 
 
 
 
Literature(247)
 
 
 
 
 
Summary(1)
 
 
BioActivity Types:
Potency(289)
 
 
 
 
 
IC50(126)
 
 
 
 
 
Ki(14)
 
 
EC50(11)
 
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 940    Data Row: 1132   Total Pages: 23   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID26748644]
Potency 0.004Confirmation Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID489007, Type: confirmatory]Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581]
View
2
[SID103163815]
GI50 0.01Growth inhibitory activity against human cancer cell line in the NCI?s anticancer drug screening program [AID247402, Type: Literature]
View
3
[SID26748644]
Potency 0.0112qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory]Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812]
View
4
[SID26748644]
Potency 0.0141Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2572, Type: confirmatory]Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812]
View
5
[SID103163815]
Ki 0.02Inhibition of rat liver CK2 by Lineweaver-Burke double reciprocal plot analysis [AID352791, Type: Literature]
View
6
[SID103163815]
IC50 0.04Inhibition of rat liver CK2 catalytic activity [AID352792, Type: Literature]
View
7
[SID103163815]
IC50 0.04Inhibition of CK2 in rat liver [AID317243, Type: Literature]
View
8
[SID103163815]
IC50 0.04Inhibition of rat liver CK2 [AID262917, Type: Literature]
View
9
[SID103163815]
IC50 0.04Inhibition of GST-fused human recombinant CK2alpha expressed in Escherichia coli HMS174 (DE3) [AID352795, Type: Literature]Casein kinase II subunit alpha [gi:55977123]
View
10
[SID103163815]
IC50 0.04Inhibition of GST-fused human recombinant CK2alpha expressed in Escherichia coli HMS174 (DE3) [AID352795, Type: Literature]Casein kinase II subunit alpha [gi:55977123]
View
11
[SID87544482]
IC50 0.04187Late stage results for the probe development effort to identify inhibitors of tRNA 2'-phosphotransferase (TPT1): Fluorescence polarization-based biochemical dose response assay for TPT1 inhibitors [AID2838, Type: confirmatory]likely tRNA 2'-phosphotransferase [Candida albicans SC5314] [gi:68476498]
View
12
[SID8139882]
Potency 0.0447qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory]Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812]
View
13
[SID26748644]
Potency 0.0708qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory]Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581]
View
14
[SID103163815]
Ki 0.081Reaction rate parameter value for phosphate with transfer with respect to ATP [AID17435, Type: Literature]
View
15
[SID26748644]
Potency 0.0891Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Assay [AID2564, Type: confirmatory]
View
16
[SID26753737]
Potency 0.1qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory]Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581]
View
17
[SID103163815]
IC50 0.1Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins [AID663960, Type: other]G-protein coupled receptor 35 [gi:68068087]
View
18
[SID103163815]
IC50 0.1Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins [AID663960, Type: other]G-protein coupled receptor 35 [gi:68068087]
View
19
[SID103163815]
IC50 0.1Desensitization of GPR35 receptor in human HT-29 cells assessed as inhibition of zaprinast-induced dynamic mass redistribution after 10 mins [AID663960, Type: other]G-protein coupled receptor 35 [gi:68068087]
View
20
[SID26748644]
Potency 0.1qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory]DNA polymerase iota [Homo sapiens] [gi:154350220]
View
21
[SID26748644]
Potency 0.1qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory]DNA polymerase iota [Homo sapiens] [gi:154350220]
View
22
[SID103163815]
IC50 0.105Antiplasmodial activity against Plasmodium falciparum Dd2 [AID544214, Type: Literature]
View
23
[SID103163815]
EC50 0.11Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay [AID663955, Type: other]G-protein coupled receptor 35 [gi:68068087]
View
24
[SID103163815]
EC50 0.11Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay [AID663955, Type: other]G-protein coupled receptor 35 [gi:68068087]
View
25
[SID103163815]
EC50 0.11Agonist activity at GPR35 receptor in human HT-29 cells after 10 mins by dynamic mass redistribution assay [AID663955, Type: other]G-protein coupled receptor 35 [gi:68068087]
View
26
[SID26748644]
Potency 0.1259qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory]15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939]
View
27
[SID26748644]
Potency 0.1259qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory]15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939]
View
28
[SID26748644]
Potency 0.1259qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory]15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939]
View
29
[SID26748644]
Potency 0.1259qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory]Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581]
View
30
[SID104171339]
Potency 0.1259qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory]DNA polymerase kappa [Homo sapiens] [gi:7705344]
View
31
[SID104171339]
Potency 0.1259qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory]DNA polymerase kappa [Homo sapiens] [gi:7705344]
View
32
[SID8139882]
IC50 0.142SMAD Transcription Factor Inhibitors Dose Response Confirmation [AID715, Type: confirmatory]mothers against decapentaplegic homolog 3 [Homo sapiens] [gi:5174513]
View
33
[SID8139882]
IC50 0.142SMAD Transcription Factor Inhibitors Dose Response Confirmation [AID715, Type: confirmatory]mothers against decapentaplegic homolog 3 [Homo sapiens] [gi:5174513]
View
34
[SID8139882]
Potency 0.1585qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory]DNA polymerase beta [Homo sapiens] [gi:4505931]
View
35
[SID8139882]
Potency 0.1585qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory]DNA polymerase beta [Homo sapiens] [gi:4505931]
View
36
[SID26748644]
Potency 0.1585qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation [AID504374, Type: confirmatory]core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873]
View
37
[SID26748644]
Potency 0.1585qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation [AID504374, Type: confirmatory]core-binding factor subunit beta isoform 2 [Homo sapiens] [gi:13124873]
View
38
[SID103163815]
IC50 0.18Antiplasmodial activity against Plasmodium falciparum FcM29 [AID544217, Type: Literature]
View
39
[SID103163815]
IC50 0.2Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry [AID639825, Type: Literature]Aldose reductase [gi:113596]
View
40
[SID103163815]
IC50 0.21Inhibition of H(+)/K(+) ATPase from pig gastric mucosa [AID334756, Type: other]
View
41
[SID103163815]
IC50 0.25Inhibition of human recombinant IGF1R expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting [AID650685, Type: Literature]Insulin-like growth factor 1 receptor [gi:124240]
View
42
[SID103163815]
IC50 0.25Inhibition of human recombinant IGF1R expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting [AID650685, Type: Literature]Insulin-like growth factor 1 receptor [gi:124240]
View
43
[SID11113162]
Potency 0.2512qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II) [AID886, Type: confirmatory]Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310]
View
44
[SID124882875]
Potency 0.2512qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory]DNA polymerase kappa [Homo sapiens] [gi:7705344]
View
45
[SID124882875]
Potency 0.2512qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory]DNA polymerase kappa [Homo sapiens] [gi:7705344]
View
46
[SID103163815]
IC50 0.26Inhibition of human recombinant TIE2 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting [AID650818, Type: Literature]Angiopoietin-1 receptor [gi:218511853]
View
47
[SID103163815]
IC50 0.26Inhibition of human recombinant TIE2 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting [AID650818, Type: Literature]Angiopoietin-1 receptor [gi:218511853]
View
48
[SID103163815]
IC50 0.3Antiplasmodial activity against Plasmodium falciparum FcB1 [AID544215, Type: Literature]
View
49
[SID103163815]
IC50 0.3Tested for in vitro inhibitory activity against tyrosine protein kinase pp60 c-src [AID219531, Type: Literature]
View
50
[SID103163815]
IC50 0.33Antiplasmodial activity against Plasmodium falciparum W2 [AID544216, Type: Literature]
View